Rezolute Inc
RZLT
NSC
Sector: Healthcare
Industry: Biotechnology
2.82
USD
-0.13
(-4.41%)
Optionable: No Market Cap: 117 M 90-day average vol: 19,434
Previous close: 2.95 Open: 2.87 Bid: 4.52 Ask: 4.52
52 week range
2.06 8.56
Last updated: Monday 26th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 0.74 |
PE Ratio (TTM) | -1.20 |
Book Value per Share ($) | 3.85 |
5 Year PE Range | NA , NA |
Returns
7 Day Return | -1.40% | |
1 Month Return | 7.63% | |
3 Month Return | -19.43% | |
1 Year Return | -63.85% | |
3 Year Return | -8.44% | |
5 Year Return | -8.44% | |
YTD Return | -41.00% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 54.29 |
14 Day SMA ($) | 2.62 |
14 Day EMA ($) | 2.74 |
Money Flow Index | 29.53 |
Average True Range | 0.25 |
50 Day SMA ($) | 2.85 |
200 Day SMA ($) | 3.48 |
ADX | 33.93 |
MACD | 0.03 |
Growth
Free Cash Flow QoQ Growth | 94.08% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -18.75% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
News
Financials
RZLT Income Statement
Annual
| Jun-12 | Jun-13 | Jun-14 | Jun-15 | Jun-16 | Jun-17 | Jun-18 | Jun-19 | Jun-20 | Jun-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of sales | 4840 | -298703 | -4 M | -134125 | -751254 | -1 M | -1 M | -49000 | -18000 | -13000 |
| Gross operating profit | -4840 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling Gen & administrative expense | -313863 | 6 M | 5 M | 6 M | 6 M | 8 M | 9 M | 7 M | 6 M | 8 M |
| Research & development expense | 0 | 3494 | 34317 | 5 M | 9 M | 12 M | 17 M | 19 M | 14 M | 15 M |
| Operating income | 309023 | -6 M | -5 M | -11 M | -15 M | -20 M | -26 M | -26 M | -21 M | -23 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -1779 | -157761 | -336489 | -662723 | 19822 | 48511 | -3 M | 395000 | 0 | 2 M |
| Pre-tax Income (EBT) | 0 | -7 M | -10 M | -11 M | -15 M | -20 M | -30 M | -30 M | -20 M | -21 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | 512757 | -7 M | -10 M | -11 M | -15 M | -20 M | -30 M | -30 M | -20 M | -21 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | 512757 | -7 M | -10 M | -11 M | -15 M | -20 M | -30 M | -30 M | -20 M | -21 M |
| Preferred dividends | N/A | N/A | N/A | N/A | 6 M | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | 512757 | -7 M | -10 M | -11 M | -21 M | -20 M | -30 M | -30 M | -20 M | -21 M |
| Depreciation | 0 | 298703 | 4 M | 134125 | 751254 | 1 M | 1 M | 49000 | 18000 | 13000 |
| Amortization | 0 | 295 | 2658 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | 292451 | -6 M | -5 M | -11 M | -14 M | -19 M | -28 M | -25 M | -20 M | -21 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | 6.25 | -54 | -52 | -27 | -42 | -28.5 | -27 | -18.41 | -3.54 | -2.72 |
| Diluted EPS total | 6.25 | -54 | -52 | -27 | -42 | -28.5 | -27 | -18.41 | -3.54 | -2.72 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today